ARCHIVES

The Selling Begins: CT Offered Beyond High-Risk Group

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

OAM Advisor’s Faxes Promote Alternatives, Cassileth Writes To NIH

September 3, 1993

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

Survey supports removal of cancer care cuts from Medicare bills.

September 26, 2003

In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely

October 29, 1993

Doubling Of Cancer Research Budget To Take Eight Years Under Obama Plan

May 15, 2009

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014